已收盘 02-06 16:00:00 美东时间
+0.320
+3.43%
LSB Industries Director Barry H. Golsen Reports Sale of Common Shares Barry H. Golsen, Director, reported a disposal of common shares of LSB Industries Inc. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative
01-24 07:00
今日重点评级关注:HC Wainwright & Co.:维持Soleno Therapeutics"买入"评级,目标价从110美元升至120美元;富国银行:维持Soleno Therapeutics"超配"评级,目标价从106美元升至114美元
01-21 11:42
In the latest quarter, 4 analysts provided ratings for LSB Industries (NYSE:LXU...
01-21 02:00
RBC Capital analyst Andrew D. Wong maintains LSB Industries (NYSE:LXU) with a Outperform and raises the price target from $10 to $11.
01-20 23:50
今日重点评级关注:HC Wainwright & Co.:维持Enlivex Therapeutics"买入"评级,目标价从7美元升至13美元;BTIG:维持Oruka Therapeutics"买入"评级,目标价从63美元升至73美元
01-13 10:18
UBS analyst Joshua Spector maintains LSB Industries (NYSE:LXU) with a Neutral and raises the price target from $9.5 to $9.75.
01-13 06:17
今日重点评级关注:Guggenheim:维持InflaRx"买入"评级,目标价从10美元升至22美元;巴克莱:维持Tandem糖尿病护理"超配"评级,目标价从51美元升至55美元
2025-11-11 10:49
RBC Capital analyst Andrew D. Wong maintains LSB Industries (NYSE:LXU) with a Outperform and raises the price target from $9 to $10.
2025-11-10 23:54
今日重点评级关注:Ascendiant Capital:维持NRX Pharmaceuticals"买入"评级,目标价从46美元升至47美元;富国银行:维持Kyverna Therapeutics"超配"评级,目标价从27美元升至31美元
2025-10-31 10:25